Woodline Partners LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$859,510
-39.6%
569,2120.0%0.01%
-36.8%
Q4 2022$1,423,030
-57.7%
569,212
-28.7%
0.02%
-59.6%
Q3 2022$3,367,000
+47.5%
797,906
-2.5%
0.05%
+34.3%
Q2 2022$2,283,000
-29.9%
818,162
+43.8%
0.04%
-34.0%
Q1 2022$3,256,000
-36.1%
569,155
+2.0%
0.05%
-27.4%
Q4 2021$5,093,000557,7990.07%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders